Combinations of small, gaseous hydrocarbons and sizable aromatics, e.g. methane and anthracene, are directly observed in a cylindrical capsule by NMR.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/b300996c | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cells.
Int J Pharm
January 2025
Centre for Pharmacy, Department of Clinical Science, University of Bergen, Norway. Electronic address:
The backbone of induction therapy in acute myeloid leukaemia (AML) is to use an anthracycline in combination with cytarabine. Despite recent advances in AML therapy, this treatment remains the standard, and it has been largely unchanged for decades. There are few curative options for patients unfit for this treatment.
View Article and Find Full Text PDFGastrointestinal-inert prebiotic micro-composites improve the growth and community diversity of mucosal-associated bacteria.
J Control Release
November 2024
Department of Biomedical Sciences, School of Infection, Inflammation, & Immunology, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address:
The process of microencapsulation and the development of microparticle-based drug formulations have gained increased pharmaceutical interest, particularly for drug delivery and bacterial-encapsulation purposes for probiotic delivery. Existing studies have examined microcomposite (MC) responses to gastrointestinal (GI) conditions with the aim of controlling disintegration, and thus release, across the small and large bowel. However, the delivery of MCs which remain intact, without degrading, could act as bacterial growth scaffolds or materials providing a prebiotic support, conferring potentially beneficial GI health properties.
View Article and Find Full Text PDFTumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery.
Nat Mater
December 2024
Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Nanoparticles are promising for drug delivery applications, with several clinically approved products. However, attaining high nanoparticle accumulation in solid tumours remains challenging. Here we show that tumour cell-derived small extracellular vesicles (sEVs) block nanoparticle delivery to tumours, unveiling another barrier to nanoparticle-based tumour therapy.
View Article and Find Full Text PDFFormation mechanism of off-flavor and the inhibition regulatory strategies in the algal oil-loaded emulsions-a review.
Crit Rev Food Sci Nutr
August 2024
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Algal oil rich in docosahexaenoic acid is easily oxidized and degraded to produce volatile short-chain compounds, leading to the deterioration of product flavor. Currently, the emulsion delivery of algal oil provides a promising approach to minimize oxidative deterioration and conceal its off-flavor. However, algal oil emulsions would also experience unanticipated oxidation as a result of the large specific surface area between the aqueous phase and the oil phase.
View Article and Find Full Text PDFProtocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.
Methods Mol Biol
July 2024
Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA, Australia.
Article Synopsis
- Genome editing tools like CRISPR systems, particularly CRISPR/Cas9, show promise for safe and customizable cancer therapies by targeting transcriptional abnormalities with minimal off-target effects.
- * Despite advances, challenges remain in effectively delivering these large dCas9 fusion proteins into cancer cells, including concerns about immune responses and the complexities of viral delivery methods.
- * The emergence of mRNA vaccine technology offers new possibilities for CRISPR/dCas9 delivery, with lipid nanoparticles (LNPs) being explored as a nonviral alternative due to their scalability and lower immunogenicity.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!